Literature DB >> 11332637

Transplantation of human neural progenitor cells to the vitreous cavity of the Royal College of Surgeons rat.

H Mizumoto1, K Mizumoto, S J Whiteley, M Shatos, H Klassen, M J Young.   

Abstract

Human neural progenitor cells, originally isolated from prenatal donor tissue at 17 weeks of development, were cultured as neurospheres and transplanted to the vitreous cavity of dystrophic Royal College of Surgeons rats with, or without, cyclosporin A immunosuppression. Donor cells were either unlabeled or prelabeled, the latter utilizing incubation with BrdU or adenoviral modification to express green fluorescent protein. Recipients of various ages were examined at 1, 2, and 4 weeks postgrafting. Transplanted human neural progenitor cells survived in the host vitreous for at least 4 weeks and maintained expression of green fluorescent protein for at least 2 weeks. After 2 weeks in vivo, grafted cells differentiated morphologically, coincident with expression of the neuronal marker MAP, indicating mature neuronal differentiation. The extensive intraretinal migration previously shown using rat progenitor cells in the Royal College of Surgeons rat model was not seen in this experiment, suggesting that high levels of neuronal migration may depend at least in part upon species-specific molecular cues. Human neural progenitor cells represent a renewable source of multipotent human cells capable of in vivo neuronal development and a potential means of delivering therapeutic factors intraocularly. Human neural progenitor cells therefore provide a useful tool for studies of neural development and differentiation in the dystrophic eye.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11332637

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  6 in total

1.  Enhanced functional integration of human photoreceptor precursors into human and rodent retina in an ex vivo retinal explant model system.

Authors:  Anat Yanai; Christopher R J Laver; Cheryl Y Gregory-Evans; Ran R Liu; Kevin Gregory-Evans
Journal:  Tissue Eng Part A       Date:  2015-03-24       Impact factor: 3.845

Review 2.  [Stem cell-based therapies for retinal disorders].

Authors:  U Bartsch; S J Linke; B Petrowitz
Journal:  Ophthalmologe       Date:  2005-07       Impact factor: 1.059

3.  Xenotransplantation of human neural progenitor cells to the subretinal space of nonimmunosuppressed pigs.

Authors:  Karin Warfvinge; Philip H Schwartz; Jens Folke Kiilgaard; Morten la Cour; Michael J Young; Erik Scherfig; Henry Klassen
Journal:  J Transplant       Date:  2011-06-01

4.  Combining chondroitinase ABC and growth factors promotes the integration of murine retinal progenitor cells transplanted into Rho(-/-) mice.

Authors:  Jian Ma; Mostafa Kabiel; Budd A Tucker; Jian Ge; Michael J Young
Journal:  Mol Vis       Date:  2011-06-29       Impact factor: 2.367

5.  Protection of visual functions by human neural progenitors in a rat model of retinal disease.

Authors:  David M Gamm; Shaomei Wang; Bin Lu; Sergei Girman; Toby Holmes; Nicholas Bischoff; Rebecca L Shearer; Yves Sauvé; Elizabeth Capowski; Clive N Svendsen; Raymond D Lund
Journal:  PLoS One       Date:  2007-03-28       Impact factor: 3.240

6.  Dexamethasone Provides Effective Immunosuppression for Improved Survival of Retinal Organoids after Epiretinal Transplantation.

Authors:  Bikun Xian; Ziming Luo; Kaijing Li; Kang Li; Mingjun Tang; Runcai Yang; Shoutao Lu; Haijun Zhang; Jian Ge
Journal:  Stem Cells Int       Date:  2019-07-25       Impact factor: 5.443

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.